AUROBINDO PHARMA
|
The Current P/S Ratio of AUROBINDO PHARMA is 2.19.
Share Price | ₹1,166.3 | Mar 27,2025 |
Market Cap | ₹67,738.7 Cr | |
Sales-TTM | ₹30,921.8 Cr | TTM-Consolidated Results |
Price/Sales | 2.19x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of AUROBINDO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹67,738.7 Cr] as on Mar 27,2025
(/) Sales [ ₹30,921.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.19x ]
Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '2.19 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AUROBINDO PHARMA !
The chart below summarizes the trend in P/S Ratio of AUROBINDO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AUROBINDO PHARMA
PS Ratio Performance Analysis for AUROBINDO PHARMA
- AUROBINDO PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.64x.
- AUROBINDO PHARMA 's operated at median p/e ratio of 1.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/e ratio peaked in Mar2024 at 2.2x.
- AUROBINDO PHARMA 's p/e ratio hit its five-year low in Mar2020 of 1.05x.
How does AUROBINDO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
AUROBINDO PHARMA | 30,921.8 | 2.19 | 67,738.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.05 | 415,373.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.12 | 155,437.0 |
CIPLA LTD | 26,981.2 | 4.44 | 119,770.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.66 | 109,188.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.11 | 96,992.9 |
MANKIND PHARMA LTD | 11,641.0 | 8.73 | 101,622.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.03 | 89,660.5 |
LUPIN LTD | 22,001.6 | 4.19 | 92,189.6 |
ABBOTT INDIA LTD | 6,243.2 | 10.41 | 64,987.3 |
ALKEM LABORATORIES LTD | 12,756.6 | 4.65 | 59,324.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AUROBINDO PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.19x |
Max industry PS | 17.12x |
Median industry PS | 4.65x |
Average industry PS | 6.96x |
You may also like the below Video Courses